Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interventional × HM781-36B × Clear all

Phase

Phase 2 10 Phase 1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cisplatin 600 Carboplatin 499 Paclitaxel 483 Cyclophosphamide 446 Radiotherapy 443 Docetaxel 407 Fluorouracil 376 Gemcitabine 357 Doxorubicin 338 Capecitabine 308 Dexamethasone 279 Oxaliplatin 242 Vincristine 232 pembrolizumab 229 Leucovorin 229 Etoposide 226 Bevacizumab 225 Rituximab 205 Prednisone 194 Pemetrexed 179 Cytarabine 177 Drug Therapy 169 Methotrexate 147 Trastuzumab 146 Irinotecan 138 Lenalidomide 123 Filgrastim 116 Nivolumab 111 Chemotherapy, Adjuvant 110 Epirubicin 106

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05378763 2026-02-18

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡